Sense of coherence or self-efficacy as predictors of health-related quality of life in sickle cell disease patients

Author:

Ahmadi MehrnazORCID,Beiranvand SamiraORCID,Poormansouri SaeedORCID,Matbouei MahsaORCID,Rohani CameliaORCID

Abstract

AbstractPatients with sickle cell disease (SCD) suffer from impaired health-related quality of life (HRQoL). This study aimed to determine the level of HRQoL, sense of coherence (SOC), and self-efficacy (SE) in a sample of SCD patients, and to explore predictors of their physical and mental HRQoL. A cross-sectional descriptive study was conducted on 83 SCD patients of one university hospital. The data of the study was collected through Persian versions of the Short-Form Health Survey SF-36 (RAND 36-item), the Sense of Coherence Scale (SOC-13), and the Sickle Cell Self-Efficacy Scale (SCSES). The mean age of the patients was 26.34 ± 8.19 years old. Patients’ mean scores for the Physical Component Summary (PCS), Mental Component Summary (MCS), SOC, and SCSES were 40.57 ± 17.18 (range: 0–100), 50.44 ± 17.95 (range: 0–100), 52.40 ± 15.35 (range: 13–91), 26.40 ± 6.96 (range: 9–45), respectively. Regression models showed that the level of the patients’ SOC, was the main predictor of the MCS (β = 0.37, p < 0.001). However, the level of the patients’ SE was the main predictor of the PCS (β = 0.30, p = 0.004). Also, “blood transfusion history” in patients was a common predictor for both the PCS (β =  − 0.28, p = 0.008) and the MCS (β =  − 0.29, p = 0.003). These results can assist nurses and clinicians to plan clinical interventions for SCD patients by focusing on increasing the level of the SOC and SE and improving SCD patients’ HRQoL. Furthermore, measuring the level of the SOC and self-efficacy as screening tests are useful to find patients with a greater risk of impaired HRQoL.

Funder

Marie Cederschiöld University

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Reference59 articles.

1. Pandarakutty S, Murali K, Arulappan J, Al Sabei SD (2020) Health-related quality of life of children and adolescents with sickle cell disease in the Middle East and North Africa region: A systematic review. Sultan Qaboos Univ Med J 20:e280

2. Ashorobi D, Ramsey A, Yarrarapu SNS, Bhatt R (2022) Sickle cell trait. In: StatPearls. Treasure Island, StatPearls Publishing 

3. Sedrak A, Kondamudi NP (2021) Sickle cell disease. StatPearls, StatPearls, Treasure Island, FL

4. Keikhaei B, Moradi-Choghakabodi P, Rahim F, Pedram M, Yousefi H, Zandian K, Samavat A (2018) A Neonatal screening for sickle cell disease in Southwest Iran. Iran J Pediatr Hematol Oncol 8:105–110

5. Badawy SM, Beg U, Liem RI, Chaudhury S, Thompson AA (2021) A systematic review of quality of life in sickle cell disease and thalassemia after stem cell transplant or gene therapy. Blood adv 5:570–83. https://doi.org/10.1182/bloodadvances.2020002948

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3